Geneos Wealth Management’s First Trust Capital Strength ETF FTCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.65M Sell
50,102
-248
-0.5% -$23.8K 0.11% 213
2025
Q4
$4.66M Sell
50,350
-2,380
-5% -$220K 0.11% 215
2025
Q3
$4.94M Sell
52,730
-321
-0.6% -$29.6K 0.13% 205
2025
Q2
$4.82M Sell
53,051
-33,486
-39% -$2.98M 0.12% 216
2025
Q1
$7.76M Buy
86,537
+56,943
+192% +$5.09M 0.11% 225
2024
Q4
$2.6M Sell
29,594
-2,028
-6% -$185K 0.09% 248
2024
Q3
$2.87M Sell
31,622
-217
-0.7% -$19K 0.11% 216
2024
Q2
$2.68M Sell
31,839
-768
-2% -$64.1K 0.12% 197
2024
Q1
$2.79M Sell
32,607
-995
-3% -$82.1K 0.13% 194
2023
Q4
$2.69M Sell
33,602
-38,246
-53% -$2.91M 0.13% 186
2023
Q3
$5.29M Sell
71,848
-8,884
-11% -$672K 0.27% 94
2023
Q2
$6.06M Sell
80,732
-1,512
-2% -$111K 0.32% 71
2023
Q1
$6M Sell
82,244
-8,427
-9% -$621K 0.36% 60
2022
Q4
$6.8M Buy
90,671
+8,031
+10% +$593K 0.41% 47
2022
Q3
$5.49M Buy
82,640
+4,986
+6% +$358K 0.38% 55
2022
Q2
$5.49M Buy
77,654
+11,432
+17% +$840K 0.27% 85
2022
Q1
$5.18M Buy
66,222
+13,901
+27% +$1.08M 0.22% 106
2021
Q4
$4.42M Sell
52,321
-14
-0% -$1.12K 0.17% 141
2021
Q3
$3.95M Buy
52,335
+2,118
+4% +$165K 0.15% 158
2021
Q2
$3.84M Sell
50,217
-8,182
-14% -$608K 0.15% 152
2021
Q1
$4.32M Sell
58,399
-8,514
-13% -$579K 0.12% 195
2020
Q4
$4.12M Buy
66,913
+36,352
+119% +$2.38M 0.17% 146
2020
Q3
$1.91M Buy
30,561
+1,657
+6% +$104K 0.1% 202
2020
Q2
$1.65M Buy
28,904
+16,378
+131% +$915K 0.09% 211
2020
Q1
$615K Buy
12,526
+4,654
+59% +$269K 0.04% 341
2019
Q4
$476K Sell
7,872
-341
-4% -$19.9K 0.03% 449
2019
Q3
$464K Sell
8,213
-318
-4% -$18.1K 0.03% 424
2019
Q2
$481K Buy
8,531
+1,067
+14% +$58.8K 0.03% 413
2019
Q1
$403K Buy
7,464
+1,269
+20% +$65.8K 0.03% 458
2018
Q4
$295K Buy
6,195
+352
+6% +$18.2K 0.02% 492
2018
Q3
$322K Sell
5,843
-362
-6% -$19.4K 0.02% 488
2018
Q2
$317K Buy
6,205
+1,095
+21% +$56.2K 0.02% 426
2018
Q1
$258K Buy
5,110
+3,577
+233% +$187K 0.02% 457
2017
Q4
$78K Buy
1,533
+494
+48% +$24.5K 0.01% 833
2017
Q3
$49K Buy
1,039
+86
+9% +$4K ﹤0.01% 947
2017
Q2
$43K Buy
953
+2
+0.2% +$90 ﹤0.01% 979
2017
Q1
$41K Buy
951
+1
+0.1% +$43 ﹤0.01% 962
2016
Q4
$38K Buy
950
+251
+36% +$10.1K 0.01% 934
2016
Q3
$28K Buy
699
+1
+0.1% +$41 ﹤0.01% 1012
2016
Q2
$27K Buy
698
+1
+0.1% +$40 ﹤0.01% 1017
2016
Q1
$27K Buy
+697
New +$25.9K ﹤0.01% 998

Other funds holding FTCS

Geneos Wealth Management's FTCS Position: Q1 2026 in Review

Geneos Wealth Management reduced its First Trust Capital Strength ETF (FTCS) stake by 0.49% in Q1 2026, selling an estimated $23.8K and leaving 50,102 shares worth $4.65M. The position accounts for 0.11% of the portfolio, ranked #213.

Geneos Wealth Management first reported a position in FTCS in Q1 2016 and has held it in 41 quarters since. The position peaked at $7.76M in Q1 2025. 540 funds tracked by Wall St. Rank hold FTCS as of Q1 2026.

  • Geneos Wealth Management held 50,102 shares of First Trust Capital Strength ETF worth $4.65M as of Q1 2026.
  • Geneos Wealth Management sold 248 First Trust Capital Strength ETF shares in Q1 2026, an estimated $23.8K.
  • First Trust Capital Strength ETF made up 0.11% of Geneos Wealth Management's portfolio in Q1 2026, its #213 holding.
  • Geneos Wealth Management first reported a position in First Trust Capital Strength ETF in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's First Trust Capital Strength ETF position peaked at $7.76M in Q1 2025.
  • 540 funds tracked by Wall St. Rank held First Trust Capital Strength ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.